28th October 2022 (8 Topics)
1
Oct
3
Oct
4
Oct
5
Oct
6
Oct
7
Oct
8
Oct
10
Oct
11
Oct
12
Oct
13
Oct
14
Oct
15
Oct
17
Oct
18
Oct
19
Oct
20
Oct
21
Oct
22
Oct
24
Oct
25
Oct
26
Oct
27
Oct
28
Oct
29
Oct
31
Oct
Tuberculosis cases surged for the first time in many years: WHO
Context
According to the recently released report on Global TB Report 2022 by WHO, highlighted the concerns over the growing cases of Tuberculosis and people dying due to the disease.
The Global TB Report:
- It was found that 6 million people fell ill due to TB in 2021 with an increase of 4.5 percent from 2020, and 1.6 million people died from TB.
- The burden of drug-resistant TB (DR-TB) also increased by 3 percent between 2020 and 2021, with 450 000 new cases of rifampicin-resistant TB (RR-TB) in 2021.
- This is the first time in many years an increase has been reported in the number of people falling ill with TB and drug-resistant TB.
- The number of people provided with treatment for RR-TB and multidrug-resistant TB and multidrug-resistant TB (MDR-TB) has also declined between 2019 and 2020.
|
Do you know?
|
About Tuberculosis (TB):
- TB is caused by a bacterium called Mycobacterium tuberculosis, belonging to the Mycobacteriaceae family consisting of about 200 members.
- In humans, TB most commonly affects the lungs (pulmonary TB), but it can also affect other organs (extra-pulmonary TB).
- TB is a very ancient disease and has been documented to have existed in Egypt as early as 3000 BC.
- TB is a treatable and curable disease.
- Transmission: TB is spread from person to person through the air. When people with lung TB cough, sneeze, or spit, they propel the TB germs into the air.
Treatments available for TB:
- Drugs:
- For previously treated cases of TB, the intensive phase is of 12 weeks, where injection of streptomycin is given for eight weeks along with four drugs FDCs (INH, Rifampicin, Pyrazinamide, and Ethambutol).
- Second-line drugs are the TB drugs that are used for the treatment of drug-resistant TB. The second line drugs include levofloxacin, moxifloxacin, bedaquiline, delamanid and linezolid.
- Vaccines: Currently, the following two vaccines have been developed and identified for TB, and are under Phase-3 clinical trial:
- VPM (Vaccine Projekt Management) 1002
- MIP (Mycobacterium Indicus Pranii)
|
Important Facts:
|
More Articles
Courses
Study
Notes
Home
Resources
More
